Cleveland Clinic

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)	depressive disorder, major depressive disorder, mood disorder, psychiatric disorder	Recruiting	Phase 3	2026-10-05		NCT07592689
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses	CNS demyelinating autoimmune disease, Nutritional and Metabolic Diseases, TDP-43 proteinopathy, acute stress disorder, adjustment disorder, amyotrophic lateral sclerosis, anxiety disorder, autoimmune disease, autoimmune disorder of the nervous system, central nervous system disorder, demyelinating disease, depressive disorder, idiopathic pulmonary fibrosis, immune system disorder, interstitial lung disease, lung disorder, metabolic disease, motor neuron disorder, multiple sclerosis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, psychiatric disorder, pulmonary fibrosis, respiratory system disorder, spinal cord disorder	Recruiting	Phase 2	2026-09-15		NCT07002034

Clinical trials